tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Outlook for Cardiff Oncology’s Onvansertib Despite Phase II Trial Challenges
PremiumRatingsPromising Outlook for Cardiff Oncology’s Onvansertib Despite Phase II Trial Challenges
2M ago
Cardiff Oncology Reports Q2 2025 Financial Results
Premium
Company Announcements
Cardiff Oncology Reports Q2 2025 Financial Results
2M ago
Closing Bell Movers: Qorvo, Starbucks jump after quarterly reports
Premium
The Fly
Closing Bell Movers: Qorvo, Starbucks jump after quarterly reports
2M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Cardiff selloff brings attractive entry point, says H.C. Wainwright
PremiumThe FlyCardiff selloff brings attractive entry point, says H.C. Wainwright
3M ago
Strategic Delay and Promising Trial Results Position Cardiff Oncology for Growth in KRAS+ Colorectal Cancer Market
Premium
Ratings
Strategic Delay and Promising Trial Results Position Cardiff Oncology for Growth in KRAS+ Colorectal Cancer Market
3M ago
Confident Buy Rating for Cardiff Oncology Amid Strategic Developments and Promising Trial Prospects
Premium
Ratings
Confident Buy Rating for Cardiff Oncology Amid Strategic Developments and Promising Trial Prospects
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100